首页|期刊导航|Virologica Sinica|HVT-based multiepitope vaccine administered subcutaneously or in ovo boosts protection of inactivated H9N2 vaccine against heterologous virus

HVT-based multiepitope vaccine administered subcutaneously or in ovo boosts protection of inactivated H9N2 vaccine against heterologous virusOA

中文摘要

H9N2 avian influenza virus(AIV)poses a persistent threat as inactivated vaccines(InV)often fail to prevent viral shedding.To address this,we developed a recombinant turkey herpesvirus(HVT-BNT)expressing conserved B and T cell epitopes from H9N2 AIV to enhance both humoral and cellular immunity.HVT-BNT exhibited genetic stability over 15 serial passages and growth kinetics comparable to the parental strain in vitro.We evaluated immunization strategies of HVT-BNT combined with InV in 1-day-old chicks and 18-day-old embryos via subcutaneous(HVT-BNT+InV)or in ovo(HVT-BNT-ovo+InV)routes,respectively.Compared to InV alone,HVT-BNT+InV elicited significantly higher HI and neutralizing antibody titers,elevated IgG and IgM levels,and increased proportions of CD8+T cells.Similarly,the HVT-BNT-ovo+InV group exhibited a trend of higher values in these indicators.Notably,while the InV group displayed no significant differences in key immune cytokines compared to the control group,the combined immunization groups exhibited significant upregulation of IFN-α,IFN-β,IFN-γ,IL-2,IL-5,IL-6,IL-10,and IL-13.Furthermore,ELISPOT assays confirmed enhanced IFN-γsecretion in response to conserved AIV peptides(NP380-393,NP455-463,and NS198-106)in the combined immunization groups.Following heterologous H9N2 AIV challenge,oropharyngeal positivity rates in the combined immunization groups were lower than those in the InV group at 5 DPI.Similarly,cloacal positivity rates were more reduced in the combined groups compared to the InV group at 3 and 5 DPI.By 7 DPI,viral shedding was completely cleared in both combined immunization groups,whereas the InV group continued to shed virus via the oropharyngeal route.These findings demonstrate that the HVT-BNT-based vaccination strategy effectively enhances both humoral and cellular immune responses,providing superior early protection.While the in ovo strategy provides a viable hatchery intervention,the subcutaneous route exhibits the superior immune activation and protection compared with conventional InV alone.

Zimin Xie;Yingyi Chen;Shanyao Du;Xiumei Huang;Yuhuan Shao;Jiangwu Huang;Ming Liao;Manman Dai

Guangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,China UK-China Centre of Excellence for Research on Avian Diseases,Guangzhou 510642,ChinaGuangdong Laboratory for Lingnan Modern Agriculture,National and Regional Joint Engineering Laboratory for Medicament of Zoonosis Prevention and Control,College of Veterinary Medicine,South China Agricultural University,Guangzhou 510642,China UK-China Centre of Excellence for Research on Avian Diseases,Guangzhou 510642,China

农业科技

H9N2 AIVHVTIn ovo immunizationMultiepitope vaccineCellular immunity

《Virologica Sinica》 2026 (2)

P.455-465,11

supported by grants from the National Natural Science Foundation of China(32473060 and 32461120064)(to MD and ML)Talent Program under the Wens Research Center of South China Agricultural University(WS-2025-WSCX-JS-000133)(to MD)the National Natural Science Foundation of Guangdong Province(2024A1515013151)(to MD)Guangzhou Basic and Applied Basic Research Project(2025A04J5445 to MD)Laboratory of Lingnan Modern Agriculture Project(NT2025005 to MD)Young Scholars of Yangtze River Scholar Professor Program(2024,Manman Dai)Young Pearl River Scholar of“Guangdong Special Support Plan”(2024,Manman Dai).

10.1016/j.virs.2026.04.008

评论